K Kamisango

Summary

Affiliation: Chugai Pharmaceutical Co
Country: Japan

Publications

  1. ncbi Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay
    K Kamisango
    Diagnostics Research Laboratories, Chugai Diagnostics Science Co, Ltd, 3 41 8 Takada, Toshima ku, Tokyo 171, Japan
    J Clin Microbiol 37:310-4. 1999
  2. ncbi Development of a hypersensitive detection method for human parvovirus B19 DNA
    K Sato
    Chugai Pharmaceutical Co Ltd, Central Research Laboratories, 3 41 8 Takada, Toshima ku, Tokyo 171 8545, Japan
    J Clin Microbiol 38:1241-3. 2000

Collaborators

Detail Information

Publications2

  1. ncbi Quantitative detection of hepatitis B virus by transcription-mediated amplification and hybridization protection assay
    K Kamisango
    Diagnostics Research Laboratories, Chugai Diagnostics Science Co, Ltd, 3 41 8 Takada, Toshima ku, Tokyo 171, Japan
    J Clin Microbiol 37:310-4. 1999
    ..Our assay has the potential to be used to monitor and determine the prognosis of HBV patients and carriers, especially during interferon treatment...
  2. ncbi Development of a hypersensitive detection method for human parvovirus B19 DNA
    K Sato
    Chugai Pharmaceutical Co Ltd, Central Research Laboratories, 3 41 8 Takada, Toshima ku, Tokyo 171 8545, Japan
    J Clin Microbiol 38:1241-3. 2000
    ..The amplified product was detected using acridinium ester-labeled DNA probes. By this method, a few copies of B19 DNA were detected in human serum albumin...